Lanfear Dennis M 4

What Happened Dennis M. Lanfear, President, CEO and a director of Coherus Oncology (CHRS), had 11,839 restricted stock unit (RSU) shares withheld to cover related tax liabilities on January 20, 2026. The shares were recorded at $1.55 each, totaling approximately $18,350. This transaction is a tax-withholding disposition (code F), not an open-market sale by the reporting person.

Key Details

• Transaction date: 2026-01-20; Filing date (Form 4): 2026-01-22 (timely filing).
• Disposition: 11,839 shares withheld at $1.55 per share; aggregate value ~$18,350.
• Transaction code: F — shares automatically withheld by the issuer to satisfy tax withholding on RSU vesting.
• No shares were sold on the open market by the reporting person in connection with this transaction (per footnote F1).
• Holdings notes: Some shares are held by the Lanfear Revocable Trust (footnote F2) and by Lanfear Capital Advisors, LLC (footnote F3); the filing excerpt does not state post-transaction total beneficial ownership.

Context Tax-withholding dispositions are routine when restricted stock units vest and do not by themselves signal insider sentiment; the company withheld shares to cover withholding obligations rather than the insider selling shares in the market. Transaction code F = tax withholding (not a purchase or voluntary sale).